HUM vs NTLA · P/E 39, rev $117.76B vs rev $57.9M
Humana Inc (HUM) versus Intellia Therapeutics Inc (NTLA) — a side-by-side from cached financials, not a winner call.
Humana Inc (HUM) is a healthcare plans company listed on NYSE.
Intellia Therapeutics Inc (NTLA) is a biotechnology company listed on US.
Latest reported HUM revenue for 2024-12-31 was $117.76B. Net income was $1.21B. Revenue was up 10.7% from 2023-12-31 to 2024-12-31. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
Latest reported NTLA revenue for 2024-12-31 was $57.9M. Net income was -$519.0M. Revenue was up 59.6% from 2023-12-31 to 2024-12-31. NTLA currently screens at market cap $1.19B.
HUM currently screens at market cap $43.46B and trailing P/E 38.6. NTLA currently screens at market cap $1.19B.
Not investment advice. Open the HUM and NTLA stock pages for the full models.
Not investment advice.